Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 64 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
631 15.8 months colorectal (metastatic) 4 Biologic therapy
Chemotherapy
Hopital Tenon France 1/2007
Treatment Details: Patients: This phase II study involved 42 patients with metastatic colorectal cancer. Twenty-four were men and 18 were women, and the median age was 60, ranging from 31-76. 67% had stage I
 
632 15.8 months Metastatic, castration-resistant prostate cancer 4 Biologic therapy
Chemotherapy
Hormone
CRCUM-Universite de Montreal Canada 9/2011
Treatment Details: Patients: This study involved men with metastatic castrate-resistant prostate cancer previously treated with docetaxel. Patients were divided into two separate treatment groups. Group A c
 
633 15.8 months Metastatic urothelial cancer 5 Chemotherapy
University Hospital Del Mar–Institut Municipal d’Investigacio Medica Spain 2/2012
Treatment Details: Patients: This phase 3 study involved patients with advanced or metastatic urothelial cancer who had not received prior chemotherapy and were divided into two separate treatment groups. Gr
 
634 15.7 months Advanced Liver Cancer 4 Biologic therapy
Chemotherapy
Zhengzhou University Affiliated Cancer Hospital China 2/2015
Treatment Details: Patients: This study involved 49 advanced hepatocellular carcinoma patients who had not been previously treated. The median patient age was 54 years and 75.5% were male. Treatment: Pat
 
635 15.7 months Bladder Cancer 4 Chemotherapy
Georges Pompidou Hospital, University Paris Descartes France 11/2014
Treatment Details: Patients: This phase 2 study involved patients with advanced or metastatic, HER2-overexpressing urothelial carcinoma who were separated into two treatment groups. Group A consisted of 29 pa
 
636 15.7 months Advanced unresectable NSCLC 4 Chemotherapy
Oncologisch Centrum Belgium 3/2007
Treatment Details: Patients: This phase II study involved 48 patients with advanced unresectable non-small cell lung cancer. The median age was 65, ranging from 39-78 years. Most of the patients were men (7
 
637 15.7 months NSCLC 4 Chemotherapy
Kyoto Prefectural University of Medicine Japan 12/2009
Treatment Details: Patients: This phase II study involved 42 patients with advanced non-small-cell lung cancer that had not received any prior treatment. The median age was 62 years (range 36-75) and 82% wer
 
638 15.7 months Newly diagnosed GBM 4 Chemotherapy
Radiation
Surgery
Istituto Neurotraumatologico Italiano Italy 11/2003
Treatment Details: Patients: This Phase II trial involved 21 patients with newly diagnosed glioblastoma multiforme. Treatment: Treatment consisted of debulking surgery or biopsy followed by radiotherapy and
 
639 15.7 months Advanced NSCLC 4 Chemotherapy
National Kinki-Central Hospital for Chest Diseases Japan 2/2003
Treatment Details: Patients: This Phase II study involved 44 patients with advanced (stage IIIB or IV) non-small cell lung cancer. All patients had not received prior chemotherapy. Treatment: Treatment con
 
640 15.6 months Advanced colorectal cancer 4 Chemotherapy
Hospital La Paz Spain 4/2004
Treatment Details: Patients: This Phase II study involved 91 patients with advanced colorectal cancer. Treatment: The treatment consisted of two chemotherapy drugs – irinotecan (CPT-11, camptosar) and ralti
 
Page 64 of 187  | Previous Page  | Next Page